A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia

Clinical trial NCT04386616 · COMPLETED

Trial details

NCT number: NCT04386616
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Pneumonia

Start date: 2020-06-02
Primary completion: 2021-01-08
Enrollment: 396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.